1
NAN MCKAY HCV SPECIALIST CERTIFICATION EXAM 2026 |
Complete Questions & Detailed Solutions | Latest Update |
Just Released | Pass Guaranteed - A+ Graded
Domain 1: HCV Epidemiology & Transmission Risk Factors
(Questions 1-15)
Q1. A 45-year-old patient with no known risk factors presents for a wellness visit.
According to the current CDC screening recommendations updated in the latest
AASLD/IDSA guidance, what is the appropriate screening approach for HCV?
A. Screen only if the patient requests testing
B. Universal one-time screening for all adults aged 18 years and older, regardless of risk
factors
C. Screen only patients with elevated liver enzymes
D. Screen only patients born between 1945 and 1965
B. Universal one-time screening for all adults aged 18 years and older, regardless
of risk factors [CORRECT]
Rationale: Current CDC and USPSTF guidelines (2019-2020 updates, reaffirmed in latest
AASLD/IDSA guidance) recommend universal one-time HCV screening for all adults ≥18
years, expanding beyond the previous birth-cohort-only (1945-1965) approach to
address rising infections among younger adults, particularly related to the opioid
epidemic. Correct Answer: B
Q2. A patient with a history of injection drug use shares needles with others. Which HCV
transmission route accounts for the majority of new infections in the United States
today?
A. Blood transfusion before 1992
B. Perinatal transmission from mother to child
C. Injection drug use and sharing of needles, syringes, or other drug preparation
,2
equipment
D. Sexual transmission between monogamous heterosexual partners
C. Injection drug use and sharing of needles, syringes, or other drug preparation
equipment [CORRECT]
Rationale: Injection drug use is the primary driver of new HCV infections in the US,
accounting for approximately 60-70% of acute cases; the opioid epidemic has
significantly increased transmission among young adults. Blood transfusions are now
rare due to screening (post-1992). Correct Answer: C
Q3. A healthcare worker sustains a needlestick injury from a patient with chronic HCV.
What is the approximate risk of HCV transmission following a percutaneous exposure to
HCV-positive blood?
A. Less than 0.1%
B. Approximately 1.8% (range 0-7%)
C. Approximately 30%
D. Approximately 90%
B. Approximately 1.8% (range 0-7%) [CORRECT]
Rationale: The average risk of HCV transmission after percutaneous exposure to HCV-
positive blood is approximately 1.8%, with a reported range of 0-7% depending on
needle type, viral load, and exposure circumstances; this is higher than HIV (0.3%) but
lower than HBV (6-30%). Correct Answer: B
Q4. A patient with HIV infection asks about their risk for HCV coinfection. Which
statement is most accurate regarding HIV-HCV coinfection?
A. HIV infection does not affect HCV acquisition risk
B. HIV infection increases HCV acquisition risk and accelerates HCV disease progression,
with higher rates of cirrhosis and hepatocellular carcinoma
,3
C. HCV infection protects against HIV progression
D. Coinfection is rare and requires no special management
B. HIV infection increases HCV acquisition risk and accelerates HCV disease
progression, with higher rates of cirrhosis and hepatocellular carcinoma
[CORRECT]
Rationale: HIV-HCV coinfection accelerates hepatic fibrosis, with cirrhosis developing 2-
3 times faster than in HCV monoinfection; HIV-induced immunosuppression impairs
HCV clearance and increases perinatal and sexual transmission risks. All HIV-positive
patients require annual HCV screening. Correct Answer: B
Q5. A patient on maintenance hemodialysis has never been tested for HCV. What is the
recommended screening frequency for this high-risk population?
A. One-time screening only
B. Screening at dialysis initiation and then annually thereafter
C. Screening every 5 years
D. Screening only if the patient develops symptoms
B. Screening at dialysis initiation and then annually thereafter [CORRECT]
Rationale: Hemodialysis patients are at increased risk for HCV transmission due to
healthcare exposure; current guidelines recommend HCV screening at dialysis initiation
and annual rescreening due to ongoing risk, with additional testing after potential
exposures. Correct Answer: B
Q6. A patient with a history of incarceration asks about HCV risk. Which epidemiologic
fact is most relevant to this population?
A. HCV prevalence in incarcerated populations is similar to the general population
B. HCV prevalence in incarcerated populations is approximately 10-20 times higher
than the general population, driven by injection drug use
, 4
C. Incarceration has no association with HCV risk
D. HCV is only transmitted through prison tattooing
B. HCV prevalence in incarcerated populations is approximately 10-20 times
higher than the general population, driven by injection drug use [CORRECT]
Rationale: Incarcerated populations have HCV prevalence of 15-30% compared to
approximately 1-2% in the general US population, primarily due to high rates of
injection drug use before and during incarceration; prison-based screening and
treatment are critical elimination strategies. Correct Answer: B
Q7. A patient asks if HCV can be transmitted through sexual contact. Which counseling
statement is most accurate?
A. HCV is never transmitted sexually under any circumstances
B. Sexual transmission of HCV is rare among monogamous heterosexual couples but
more common among men who have sex with men (MSM) with high-risk behaviors,
particularly those with HIV coinfection or engaging in traumatic sexual practices
C. HCV is as easily transmitted sexually as HIV
D. Condoms are unnecessary for HCV prevention in all populations
B. Sexual transmission of HCV is rare among monogamous heterosexual couples
but more common among men who have sex with men (MSM) with high-risk
behaviors, particularly those with HIV coinfection or engaging in traumatic sexual
practices [CORRECT]
Rationale: HCV sexual transmission is inefficient in monogamous heterosexual couples
(<1-3% per year); however, MSM with HIV, multiple partners, or traumatic sexual
practices have significantly higher transmission rates, warranting annual screening.
Correct Answer: B
Q8. A pregnant patient with chronic HCV asks about perinatal transmission risk. What is
the approximate risk of mother-to-child HCV transmission?
NAN MCKAY HCV SPECIALIST CERTIFICATION EXAM 2026 |
Complete Questions & Detailed Solutions | Latest Update |
Just Released | Pass Guaranteed - A+ Graded
Domain 1: HCV Epidemiology & Transmission Risk Factors
(Questions 1-15)
Q1. A 45-year-old patient with no known risk factors presents for a wellness visit.
According to the current CDC screening recommendations updated in the latest
AASLD/IDSA guidance, what is the appropriate screening approach for HCV?
A. Screen only if the patient requests testing
B. Universal one-time screening for all adults aged 18 years and older, regardless of risk
factors
C. Screen only patients with elevated liver enzymes
D. Screen only patients born between 1945 and 1965
B. Universal one-time screening for all adults aged 18 years and older, regardless
of risk factors [CORRECT]
Rationale: Current CDC and USPSTF guidelines (2019-2020 updates, reaffirmed in latest
AASLD/IDSA guidance) recommend universal one-time HCV screening for all adults ≥18
years, expanding beyond the previous birth-cohort-only (1945-1965) approach to
address rising infections among younger adults, particularly related to the opioid
epidemic. Correct Answer: B
Q2. A patient with a history of injection drug use shares needles with others. Which HCV
transmission route accounts for the majority of new infections in the United States
today?
A. Blood transfusion before 1992
B. Perinatal transmission from mother to child
C. Injection drug use and sharing of needles, syringes, or other drug preparation
,2
equipment
D. Sexual transmission between monogamous heterosexual partners
C. Injection drug use and sharing of needles, syringes, or other drug preparation
equipment [CORRECT]
Rationale: Injection drug use is the primary driver of new HCV infections in the US,
accounting for approximately 60-70% of acute cases; the opioid epidemic has
significantly increased transmission among young adults. Blood transfusions are now
rare due to screening (post-1992). Correct Answer: C
Q3. A healthcare worker sustains a needlestick injury from a patient with chronic HCV.
What is the approximate risk of HCV transmission following a percutaneous exposure to
HCV-positive blood?
A. Less than 0.1%
B. Approximately 1.8% (range 0-7%)
C. Approximately 30%
D. Approximately 90%
B. Approximately 1.8% (range 0-7%) [CORRECT]
Rationale: The average risk of HCV transmission after percutaneous exposure to HCV-
positive blood is approximately 1.8%, with a reported range of 0-7% depending on
needle type, viral load, and exposure circumstances; this is higher than HIV (0.3%) but
lower than HBV (6-30%). Correct Answer: B
Q4. A patient with HIV infection asks about their risk for HCV coinfection. Which
statement is most accurate regarding HIV-HCV coinfection?
A. HIV infection does not affect HCV acquisition risk
B. HIV infection increases HCV acquisition risk and accelerates HCV disease progression,
with higher rates of cirrhosis and hepatocellular carcinoma
,3
C. HCV infection protects against HIV progression
D. Coinfection is rare and requires no special management
B. HIV infection increases HCV acquisition risk and accelerates HCV disease
progression, with higher rates of cirrhosis and hepatocellular carcinoma
[CORRECT]
Rationale: HIV-HCV coinfection accelerates hepatic fibrosis, with cirrhosis developing 2-
3 times faster than in HCV monoinfection; HIV-induced immunosuppression impairs
HCV clearance and increases perinatal and sexual transmission risks. All HIV-positive
patients require annual HCV screening. Correct Answer: B
Q5. A patient on maintenance hemodialysis has never been tested for HCV. What is the
recommended screening frequency for this high-risk population?
A. One-time screening only
B. Screening at dialysis initiation and then annually thereafter
C. Screening every 5 years
D. Screening only if the patient develops symptoms
B. Screening at dialysis initiation and then annually thereafter [CORRECT]
Rationale: Hemodialysis patients are at increased risk for HCV transmission due to
healthcare exposure; current guidelines recommend HCV screening at dialysis initiation
and annual rescreening due to ongoing risk, with additional testing after potential
exposures. Correct Answer: B
Q6. A patient with a history of incarceration asks about HCV risk. Which epidemiologic
fact is most relevant to this population?
A. HCV prevalence in incarcerated populations is similar to the general population
B. HCV prevalence in incarcerated populations is approximately 10-20 times higher
than the general population, driven by injection drug use
, 4
C. Incarceration has no association with HCV risk
D. HCV is only transmitted through prison tattooing
B. HCV prevalence in incarcerated populations is approximately 10-20 times
higher than the general population, driven by injection drug use [CORRECT]
Rationale: Incarcerated populations have HCV prevalence of 15-30% compared to
approximately 1-2% in the general US population, primarily due to high rates of
injection drug use before and during incarceration; prison-based screening and
treatment are critical elimination strategies. Correct Answer: B
Q7. A patient asks if HCV can be transmitted through sexual contact. Which counseling
statement is most accurate?
A. HCV is never transmitted sexually under any circumstances
B. Sexual transmission of HCV is rare among monogamous heterosexual couples but
more common among men who have sex with men (MSM) with high-risk behaviors,
particularly those with HIV coinfection or engaging in traumatic sexual practices
C. HCV is as easily transmitted sexually as HIV
D. Condoms are unnecessary for HCV prevention in all populations
B. Sexual transmission of HCV is rare among monogamous heterosexual couples
but more common among men who have sex with men (MSM) with high-risk
behaviors, particularly those with HIV coinfection or engaging in traumatic sexual
practices [CORRECT]
Rationale: HCV sexual transmission is inefficient in monogamous heterosexual couples
(<1-3% per year); however, MSM with HIV, multiple partners, or traumatic sexual
practices have significantly higher transmission rates, warranting annual screening.
Correct Answer: B
Q8. A pregnant patient with chronic HCV asks about perinatal transmission risk. What is
the approximate risk of mother-to-child HCV transmission?
